Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michelle Louise O'Donoghue, M.D.

Co-Author

This page shows the publications co-authored by Michelle O'Donoghue and Douglas Kiel.
Connection Strength

0.053
  1. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study. Lancet Diabetes Endocrinol. 2019 12; 7(12):899-911.
    View in: PubMed
    Score: 0.053
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.